SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Mar 7, 2017
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: March 7, 2017 · CIK: 0001433607 · Accession: 0001493152-17-002193
AI Filing Summary & Sentiment
File numbers found in text: 333-215682
Show Raw Text
CORRESP
1
filename1.htm
March
7, 2017
VIA
EDGAR
United
States Securities and Exchange Commission
100
F Street, NE
Washington,
D.C. 20549Attention:
Ms.
Heather Percival
Mr.
Geoff Kruczek
Ms.
Amanda Ravitz
Re:
InspireMD,
Inc.
Registration
Statement on Form S-1, originally filed on January 24, 2017
File
No. 333-215682, as amended (the “Registration Statement”)
Request
for Acceleration
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins
the request of InspireMD, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared
effective at 4:00 p.m. (Washington, D.C. time) on March 8, 2017, or as soon as practicable thereafter.
Pursuant
to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise you that we have
effected the distribution of 344 copies to institutions and individuals of the Company’s preliminary prospectus dated March
6, 2017 through the date hereof.
We
have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Dawson
James Securities, Inc.
By:
/s/
Thomas W. Hands
Name:
Thomas
W. Hands
Title:
President